Defibrotide (DF) is effective in the treatment of severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Results of a phase II, multicenter, randomized study.

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Richardson, P; Soiffer, RJ; Antin, JH; Jin, Z; Vredenburgh, JJ; Kurtzberg, J; Martin, PL; Hockenbery, D; Steinbach, G; Murray, KF; Vogelsang, GB; Chen, A; Krishnan, A; Prasad, VK; Warren, DL; Momtaz, P; Batchelder, A; Wei, LJ; Rifai, N; Bradwin, G; Iacobelli, M; McDonald, GB; Guinan, EC

Published Date

  • November 16, 2003

Published In

Volume / Issue

  • 102 / 11

Start / End Page

  • 193A - 193A

Published By


  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 45th Annual Meeting of the American-Society-of-Hematology

Conference Location


Conference Start Date

  • December 6, 2003

Conference End Date

  • December 9, 2003